1286 studies found for:    CARE-MS
Show Display Options
Rank Status Study
1 Completed Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies
Condition: Multiple Sclerosis
2 Completed
Has Results
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: Alemtuzumab;   Biological: Interferon beta-1a
3 Completed
Has Results
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: Alemtuzumab 12 mg;   Biological: Alemtuzumab 24 mg;   Biological: Interferon beta-1a
4 Active, not recruiting An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Biological: alemtuzumab
5 Enrolling by invitation Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS)
Condition: Relapsing Remitting Multiple Sclerosis
6 Not yet recruiting Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
Conditions: Multiple Sclerosis;   Pain;   Depression
Intervention: Behavioral: Collaborative Care (CC)
7 Completed Development and Evaluation of a New Palliative Care Service for People Severely Affected With Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Intervention: Procedure: Palliative care service
8 Recruiting Acupuncture or MBSR for Patients With Fatigue and MS
Conditions: Fatigue;   Multiple Sclerosis
Interventions: Other: Usual care + acupuncture;   Other: usual care+mbsr;   Other: usual care
9 Not yet recruiting Study to Evaluate Fatigue in Participants With Relapsing Remitting Multiple Sclerosis When Treated With BG00012 or Standard of Care
Conditions: Relapsing-Remitting Multiple Sclerosis;   Multiple Sclerosis
Interventions: Drug: BG00012 (Dimethyl Fumarate);   Other: Standard of Care (SOC) First Line Treatements
10 Completed Exercise in Severely Disabled Patients With MS
Condition: Multiple Sclerosis
Interventions: Behavioral: Endurance training;   Behavioral: Standard care
11 Recruiting Complementary and Alternative Care in Multiple Sclerosis
Condition: Multiple Sclerosis
12 Completed Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy
Condition: Multiple Sclerosis
Intervention: Procedure: NAbs testing
13 Completed Cognitive Behavioural Therapy Software for the Treatment of Depression in People With Multiple Sclerosis
Conditions: Depression;   Multiple Sclerosis
Interventions: Other: CBT Software;   Other: Treatment as usual
14 Completed Accuracy of Point of Care (POC) or In-office Urine Drug Testing (Immunoassay) in Chronic Pain Patients
Condition: Chronic Pain
Intervention: Other: Urine Drug Testing
15 Completed Pain Medicine for Wound Care Procedures
Conditions: Wound Care;   Pain Intensity;   Hyperalgesia;   Nausea;   Vomiting;   Hallucinations
Interventions: Drug: morphine plus saline;   Drug: morphine plus ketamine
16 Not yet recruiting A Pilot Randomized Trial of a Comprehensive Transitional Care Program for Colorectal Cancer Patients
Conditions: Colorectal Cancer;   Comprehensive Transitional Care Program
Interventions: Other: Patient education: One-on-one visit;   Other: Discharge planning: Assessment of barriers to discharge;   Other: Medication reconciliation: Patient medication review;   Other: Appointment before discharge: Additional measure to ensure awareness of next clinic visit;   Other: Transition coach;   Other: Patient-centered discharge instructions: Enhanced;   Other: Provider continuity: Specific surgeons responsible for coordinating care with medical/radiation oncology;   Other: Timely follow-up: Barriers to clinic follow-up visits will be discussed;   Other: Timely PCP communication;   Other: Follow-up telephone call;   Other: Patient hotline: 24 hour follow-up following call to Ask My Nurse number
17 Completed Patients With RRMS:Candidates for MS Therapy Change
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: Fingoliomod;   Drug: Interferon beta 1a or interferon beta 1b or Glatiramer Acetate
18 Completed Safety Study of Natalizumab to Treat Multiple Sclerosis (MS)
Conditions: Relapsing-Remitting Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis
Interventions: Drug: natalizumab;   Other: standard of care
19 Completed FlexToBa for People With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Behavioral: Home-based, DVD-delivered physical activity;   Behavioral: Behavioral: Usual care/Wait list
20 Completed An Enhanced Medical Home for High-Risk Chronically Ill Children
Condition: Chronic Illnesses
Interventions: Other: Comprehensive care medical home;   Other: Usual Care

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years